How Midol, a period relief product, is fighting the normalization of discomfort

MidolBayer
Written By On Strategy Showcase

Kelly Fanning
General Manager
U.S. Pain, Cardio & Dermatology
Bayer
New York City

Connect with Kelly
LinkedIn

Andrea Schulz
Group Strategy Director
MullenLowe U.S.

Connect with Andrea
LinkedIn / MullenLowe

 

Midol is provoking people with periods to question the normalization of discomfort by reaching for multi-symptom relief. Be sure to see the creative work on our website.  We're joined by Kelly Fanning of Bayer and Andrea Shulz of MullenLowe U.S.

On Strategy Showcase
Previous

Chipotle's "Food with Integrity" platform and its 33 million person database
Next

The inside story behind McDonald's global "As Featured In" campaign from W+K